VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,268,512 | -60.5% | 455,551 | +3.4% | 0.00% | -66.7% |
| Q2 2023 | $10,810,788 | -6.2% | 440,717 | -11.0% | 0.00% | 0.0% |
| Q1 2023 | $11,525,818 | -8.2% | 495,308 | -0.2% | 0.00% | -25.0% |
| Q4 2022 | $12,559,479 | +28.7% | 496,226 | -1.9% | 0.00% | +33.3% |
| Q3 2022 | $9,755,000 | -21.1% | 505,946 | +4.2% | 0.00% | -25.0% |
| Q2 2022 | $12,370,000 | +1096.3% | 485,660 | +1108.5% | 0.00% | – |
| Q1 2022 | $1,034,000 | -86.5% | 40,188 | -78.1% | 0.00% | -100.0% |
| Q4 2021 | $7,671,000 | +403.3% | 183,201 | +423.3% | 0.00% | – |
| Q3 2021 | $1,524,000 | +3.0% | 35,008 | +11.9% | 0.00% | – |
| Q2 2021 | $1,479,000 | +65.8% | 31,290 | +79.8% | 0.00% | – |
| Q1 2021 | $892,000 | +191.5% | 17,398 | +52.1% | 0.00% | – |
| Q4 2020 | $306,000 | -68.6% | 11,438 | -51.9% | 0.00% | – |
| Q2 2020 | $975,000 | – | 23,804 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $14,609,161 | 17.42% |
| SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $156,329,464 | 1.29% |
| Octagon Capital Advisors LP | 325,050 | $3,045,719 | 0.47% |
| SECTOR GAMMA AS | 148,538 | $1,391,801 | 0.36% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1,345,635 | $12,608,600 | 0.31% |
| ALGERT GLOBAL LLC | 449,685 | $4,214 | 0.20% |
| Quantamental Technologies LLC | 18,519 | $173,523 | 0.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 47,000 | $439,920 | 0.15% |
| DUALITY ADVISERS, LP | 123,871 | $1,160,671 | 0.14% |
| Empowered Funds, LLC | 385,135 | $3,608,715 | 0.11% |